Osaic Holdings’s AN2 Therapeutics ANTX Stock Holding History

Osaic Holdings’s Portfolio ANTX Stock Details ANTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03K	Hold	300	–	–	﹤0.01%	7260
2025 Q4	$342	Hold	300	–	–	﹤0.01%	7500
2025 Q3	$384	Hold	300	–	–	﹤0.01%	7591
2025 Q2	$318	Hold	300	–	–	﹤0.01%	7440
2025 Q1	$408	Hold	300	–	–	﹤0.01%	7043
2024 Q4	$414	Hold	300	–	–	﹤0.01%	7058
2024 Q3	$321	Hold	300	–	–	﹤0.01%	7091
2024 Q2	$645	Hold	300	–	–	﹤0.01%	6923
2024 Q1	$975	Hold	300	–	–	﹤0.01%	6686
2023 Q4	$6.15K	Buy	300 +100	+50%	+$1.67K	﹤0.01%	6073
2023 Q3	$3.22K	Hold	200	–	–	﹤0.01%	6443
2023 Q2	$1.7K	Hold	200	–	–	﹤0.01%	6727
2023 Q1	$1.97K	Hold	200	–	–	﹤0.01%	6718
2022 Q4	$2K	Hold	200	–	–	﹤0.01%	6609
2022 Q3	$3K	Hold	200	–	–	﹤0.01%	6574
2022 Q2	$2K	Buy	+200	New	+$2.65K	﹤0.01%	6837

Other funds holding ANTX

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SSC

Spruce Street Capital New York $416M AUM

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Osaic Holdings's ANTX Position: Q1 2026 in Review

Osaic Holdings held its AN2 Therapeutics (ANTX) position steady in Q1 2026 at 300 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #7260.

Osaic Holdings first reported a position in ANTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.15K in Q4 2023. 52 funds tracked by Wall St. Rank hold ANTX as of Q1 2026.

Osaic Holdings held 300 shares of AN2 Therapeutics worth $1.03K as of Q1 2026.
Osaic Holdings left its AN2 Therapeutics share count unchanged in Q1 2026.
AN2 Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7260 holding.
Osaic Holdings first reported a position in AN2 Therapeutics in Q2 2022 and has held it in 16 quarters since.
Osaic Holdings's AN2 Therapeutics position peaked at $6.15K in Q4 2023.
52 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.